Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balixafortide for CD34+ Cell Mobilization in Multiple Myeloma
NCT01105403Phase 2Completed
- Sponsor
- Polyphor
- Start
- Apr 2009
- Primary completion
- Feb 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of balixafortide in multiple myeloma (MM), sponsored by Polyphor. Started Apr 2009; status: completed.
02
Drugs
balixafortide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01105403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105403.